HLA-DR3

From WikiMD's WELLNESSPEDIA

HLA-DR3 is a human leukocyte antigen serotype within the HLA-DR serotype group. The serotype is determined by the antibody recognition of antigens. HLA-DR3 is a split antigen of the broad antigen HLA-DR17, which is now obsolete. HLA-DR3 is associated with several autoimmune diseases, including type 1 diabetes, coeliac disease, and systemic lupus erythematosus.

Structure and Function[edit]

HLA-DR3 is a cell surface glycoprotein that plays a crucial role in the immune system. It is part of the major histocompatibility complex (MHC) class II, which presents antigens to the T cells. The HLA-DR3 antigen is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane.

Disease Associations[edit]

HLA-DR3 is associated with a variety of autoimmune diseases. These include:

  • Type 1 diabetes: HLA-DR3 and HLA-DR4 are the most common serotypes associated with this disease. The presence of these serotypes increases the risk of developing type 1 diabetes.
  • Coeliac disease: HLA-DR3 is found in up to 95% of patients with coeliac disease. The presence of HLA-DR3 is a strong predictor of the development of coeliac disease.
  • Systemic lupus erythematosus: HLA-DR3 is associated with an increased risk of developing systemic lupus erythematosus, particularly in individuals of European descent.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.